Systemic Anti-VEGF Therapy May Be A Treatment Option In Certain Patients

Ocular Surgery News

Systemic infusion of bevacizumab may be offered to some patients with wet age-related macular degeneration who refuse or cannot receive intravitreal injections, according to a study.
  • <<
  • >>

Comments